Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| ORBOTECH LTD | ORBK | 10.86% |
| NOAH HOLDING | NOAH | 9.92% |
| SONIC FOUNDR | SOFO | 9.45% |
| VIPSHOP HOLD | VIPS | 9.20% |
| RENEWABLE EN | REGI | 8.98% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
DeVry, Inc. ( DV - Analyst Report ) recently launched graduate certificate programs in nursing education and nursing informatics under its Chamberlain College of Nursing. The introduction of the courses is in response to the growing demand for certified nurses. Applications are being accepted for the spring semester starting from January 2013.
The duration of the Graduate Certificate in Nursing Education is 12 to 15 semester credit hours and Nursing Informatics is 9 to 15 credit hours. The courses may include one or two 100-hour education practicum. The courses focus on competencies required to take major nursing examinations.
These courses have been designed to upgrade the skills of nurse educators and practicing nurses. The students can also opt for online courses with or without the practicum. The nurses are trained to use latest technology so that they can function in highly digitized healthcare settings.
DeVry witnessed solid new enrollment growth in Chamberlain College of Nursing and in other institutions like Carrington Colleges in the first quarter of 2013, owing to strong demand for medical courses. Total enrollments increased 20.2% at the Chamberlain College of Nursing and 2.1% at DeVry Medical International. Medical and Healthcare segment revenue grew 7.4% year over year in the quarter, driven by solid new enrollment growth.
DeVry, a peer of Apollo Group Inc. ( APOL - Analyst Report ) , carries a Zacks #2 Rank in the near term (Buy rating). Continued progress on its performance improvement plan to align costs, regain enrollment growth and make growth investments, helped the company to deliver better-than-expected results in the first quarter fiscal 2013. The first quarter results were a turnaround from the past few weak quarterly results, thus justifying the short-term buy rating.
Read the full reports :
Analyst Report on APOL
Analyst Report on DV